COURSE DESCRIPTION:
This is a buprenorphine prescribing training workshop for New Jersey licensed physicians, nurse practitioners and physician assistants that includes 5.5 hours of in-person training at the conference, followed by 4-hours of online training that attendees will complete within 90 days after the conference. Attendees will receive a $750 honorarium for completing both the in-person and online training.  The workshop fulfills the 8-hours of training required to apply for a waiver to prescribe buprenorphine for treatment of an opioid use disorder. The workshop will include both didactic lectures and breakout groups including discussion of clinical cases. The session will cover core content, mandated by the federal training requirement, as well as practical information to connect patients to needed specialty care and social services and how to receive mentoring and support. RowanSOM is helping to make this initiative possible with grant funding from the State of New Jersey. 
 
CREDIT DESIGNATION:
NJAOPS designates this live activity for a maximum of 5.5 AOA Category 1-A CME credits and for a maximum of  5.5 AMA PRA Category 1 Credit(tm).  Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
​LEARNING OBJECTIVES
Upon completion of this session, participants will be able to:

1. List clinical factors that are important for selecting patients for office-based buprenorphine/naloxone treatment.
2. Understand the clinically relevant pharmacology of buprenorphine/naloxone, extended release naltrexone and methadone.
3. Describe the resources needed to establish office-based treatment with buprenorphine/naloxone and other medications to treat patients with opioid use disorders.

 
1:30p - 1:40p       
Registration / Sign-In
 
1:40p - 1:45p       
Welcome and Introduction – Ryan Schmidt, MD

1:45p - 2:15p       
Overview: Opioid Use Disorder Tx with Bup/Naloxone – Kaitlan Baston, MD

• Taking a Substance Use History
• DSM V Criteria for Diagnosing Opiate Use Disorders
• Detecting Substance Use (Urine Screening)
• Co-Occurring Psychiatric Disorders
• Determining the Appropriateness of Office-based Buprenorphine/Naloxone Treatment

 
2:15p – 2:45p      
Patient Evaluation – Matthew Salzman, MD

• Taking a Substance Use History
• DSM V Criteria for Diagnosing Opiate Use Disorders
• Detecting Substance Use (Urine Screening)
• Co-Occurring Psychiatric Disorders
• Determining the Appropriateness of Office-based Buprenorphine/Naloxone Treatment

 
2:45p – 3:10p      
Case Study #1  (breakout session 1)

3:10p – 3:40p      
Specialty Topics

• Dual Diagnosis - Richard Jermyn, DO
• Pain - Richard Jermyn, DO
• Perinatal Patients – Kaitlan Baston, MD

 
3:40p – 4:05p      
Case Study #2  (breakout session 2)
 
4:05p – 4:35p      
Medication Assisted Treatment Clinical Application – Ryan Schmidt, MD

• Introduction
• Stabilization
• Maintenance
• Withdrawal
• Use of Extended Release Naltrexone 

4:35p – 4:55p      
Case Study #3 
(breakout session 3)                                                
 
4:55p – 5:10p      
Urine Drug Testing  & Overview of Clinical Tools – Matthew Salzman, MD
 
5:10p – 5:15p      
Brief Instructions: Completing the Online Portion of the training and Completing the NOI Waiver Form- Kaitlan Baston, MD
 
5:15p - 5:45p       
Intro to New Jersey Specific Resources, Reimbursement, and Structure – Richard Jermyn, DO & Ryan Schmidt, MD
 
5:45p - 7:15p       
Breakout sessions by county/region
This final portion of the training will encompass 1.5 hours of New Jersey training regarding specific treatment and recovery support services available in different regions of New Jersey